TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CGON

CG Oncology, Inc.

Healthcare · Biotechnology

74.60$ -1.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

CG Oncology, Inc. (CGON) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -132 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CGON
Line item 2021 2022 2023 2024 2025
-14 -30 -46 -79 -132
0.0 0.0 0.0 0.0 1.4
1.1 0.7 1.5 11 27
-2.0 4.4 3.4 2.9 2.3
0.1 0.0 0.0 0.2 0.1
-0.1 -55 -121 -301 -246
15 0.0 -16 -0.4 0.0
15 120 87 628 154
1.7 35 -80 249 -225
-14 -30 -46 -79 -132

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?